Texas Senators will begin discussing a bill to clamp down on products that contain the active ingredient in marijuana.

Enovix is strategically positioned to meet the growing demand for high-capacity batteries. Click here to read why ENVX stock ...

Dutch ingredients start-up Vivici has announced the U.S. launch of its Vivitein BLG (beta-lactoglobulin) protein produced ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, a leading, independent developer of high-quality ...

Under terms of the deal, Gubra will receive an initial $350 million payment and could earn up to $1.875 billion more in ...

METiS Pharmaceuticals, a clinical-stage, AI-driven biotechnology company specializing in innovative drug delivery ...

Texas Senate Bill 3 proposes a ban on consumable THC products with severe penalties for possession and manufacture.

Corvus Pharmaceuticals' Soquelitinib shows promise for PTCL & more, but financial risks and competition raise concerns. Learn more about CRVS stock here.

AbbVie (ABBV) on Monday said it struck a licensing deal with Danish biotechnology company Gubra to develop a potential candidate for obesity treatment. AbbVie will be responsible for the global ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

India’s R&D Spending Soars Under Modi Government, Catalyzing Innovation in AI, Biotechnology, and Quantum Computing.

ST. LOUIS, March 03, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for ...